Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A detailed zero-based budgeting guide helps you plan meticulously. Define categories, set limits, and review results to refine your plan.
19,855 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A pivotal quarter could set the tone for Micron in 2026. This guide breaks down what happened, why it happened, and h...
A July 2026 mid-year review spots Coca-Cola, Procter & Gamble, and Johnson & Johnson as the leading dividend aristocr...
AI funding is surging in 2026, signaling a new investment wave. Here's how an investor ahead next investment can posi...
Curious whether to reach for Sprott Gold Miners Global (SGDM) or Global X Silver Miners (SIL)? This guide breaks down...
Two memory names draw heavy investor attention as AI and data-center growth power demand. This guide examines whether...
Tesla's robotaxi just launched in Miami, signaling a new era for the company’s autonomous ride-hailing push. This art...
A New York tech startup is financing workers’ housing near its expensive offices, spending roughly $1.7 million annua...
SpaceX joins the Nasdaq-100, setting up a mechanical buy flow for index funds. Analysts estimate about $4.3 billion i...
Century 21 is accelerating mergers and acquisitions driven by growing technology demands, completing 16 deals in 2026...
When a top investor adds to a position after a selloff, it can reveal confidence not just in a single company, but in...
Kelley Blue Book unveils Kelley Blue Book Homes, a real estate lead platform that pays upfront to access seller leads...